The Street’s Key Stock Analysts Research Reports
$AMZN, $ANTM, $AAPL, $BIO, $BP, $CSX, $DRI, $HUM, $MDLZ
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Thursday, as follows:
Amazon.com Inc. (NASDAQ:AMZN) was reiterated as Buy and the price target was raised to 2,450 from 2,200 at DA Davidson. Amazon’s shares hit a $1-T market cap Tuesday.
Anthem Inc. (NYSE:ANTM) was raised to Overweight from Equal Weight and the price target was raised to 368 from 273 at Morgan Stanley.
Apple Inc. (NASDAQ:AAPL) analysts reiterated as Overweight and the price target was raised to 245 from 232 at Morgan Stanley. The call is ahead of an expected iPhone refresh and is similar to a Canaccord Genuity call Tuesday. The consensus target price was 219.50, and the 52-wk trading range is 149.16 – 228.87.
Bio-Rad Laboratories Inc. (NYSE:BIO) was started as Equal Weight with a 345 target price at Barclays.
BP PLC (NYSE:BP) was raised to Overweight from Equal Weight at Morgan Stanley. BP’s 52-wk trading range is 34.78 – 47.83 and its consensus target price was 49.08.
CSX Corp. (NYSE:CSX) was downgraded to Market Perform from Outperform at BMO Capital Markets.
Darden Restaurants Inc. (NYSE:DRI) analysts reiterated as Buy and the price target was raised to 125 from 115 at Stifel.
Humana Inc. (NYSE:HUM) was maintained as Overweight and the price target was raised to 400 from 365 at Morgan Stanley.
Mondelez International Inc. (NASDAQ:MDLZ) was reiterated as Outperform and the price target was raised to 52 from 48 at Wells Fargo
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Reports - November 21, 2019
- Gold Price Outlook: Gold Set Up for a Holiday Rally - November 21, 2019
- Men Maintaining Muscle Mass in Middle-age May Lower Risk of Heart Disease - November 21, 2019